Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
HROW similar filings
- 4 Feb 21 Surface Ophthalmics Announces First Patient Dosed in Phase II Trial for SURF-200 for Acute Dry Eye
- 27 Jan 21 Surface Ophthalmics Announces First Patient Dosed in Landmark Head-to-Head Phase II Trial for SURF-100 for Chronic Dry Eye Disease
- 21 Jan 21 Investigational therapy SURF-201 met all primary endpoints for the treatment of pain and inflammation following cataract surgery
- 17 Nov 20 Regulation FD Disclosure
- 17 Nov 20 Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
- 9 Nov 20 Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
- 30 Sep 20 Departure of Directors or Certain Officers
Filing view
External links